Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07056062 · ClinicalTrials.gov registry record · Phase 2
Oral Calcium Supplementation in Labor
A Phase 2 study of Labor Complication and Labor, sponsored by Arrowhead Regional Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 89
- Enrollment target
- 1
- Study location
NCT07056062: Completed Phase 2 study of Labor Complication and Labor, sponsored by Arrowhead Regional Medical Center.
NCT07056062 is a Phase 2 study of Labor Complication and Labor that has completed, run by Arrowhead Regional Medical Center. The registered enrollment target is 89 participants, below the 299-participant average among 5 other Labor Complication trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07056062, a Phase 2 study of Labor Complication and Labor, has completed, sponsored by Arrowhead Regional Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 89 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if oral calcium carbonate can improve uterine contractions and labor outcomes in term pregnancies. It will also evaluate the safety of calcium carbonate when used during labor. The main questions it aims to answer are: Does oral calcium carbonate increase uterine contraction strength? Does it lead to shorter labor duration or higher vaginal delivery rates? What side effects or complications, if any, occur with calcium carbonate use during labor? Researchers will compare oral calcium carbonate to no treatment to see if it helps improve labor efficiency and reduce cesarean delivery rates. Participants will: Be randomly assigned to receive either 2,000 mg of oral calcium carbonate or no intervention Undergo monitoring with an intrauterine pressure catheter to measure contraction strength Be observed for two hours without oxytocin to assess calcium's direct effect on contractions Have data collected on labor progression, delivery outcomes, and neonatal health
Primary Outcome
Recording the number of contractions in a ten-minute period for 2 hours
Conditions Studied
Interventions
- DRUG Calcium carbonate
Study Locations (1)
California
- Arrowhead Regional Medical Center - Colton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2024-04-30 |
| Est. Completion | 2025-05-30 |
| Phase | Phase 2 |
What the finished NCT07056062 record still lists
NCT07056062 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 299-participant average among 5 other Labor Complication trials with a reported enrollment target (70% lower).
The record links to 7 conditions, with Labor Complication appearing as the primary indexed condition, and to 1 intervention - of which Calcium carbonate is the first listed.
NCT07056062 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07056062 about?
NCT07056062 is a clinical study titled "Oral Calcium Supplementation in Labor". The goal of this clinical trial is to learn if oral calcium carbonate can improve uterine contractions and labor outcomes in term pregnancies. It will also evaluate the safety of calcium carbonate when used during labor. The main questions it aims to answer are: Does oral calcium carbonate increase...
What is the current status of trial NCT07056062?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 89 participants. The study started on 2024-04-30. Estimated completion is 2025-05-30.
What conditions does trial NCT07056062 study?
This clinical trial studies the following conditions: Labor Complication, Labor, Labor Dystocia, Uterine Contraction, Labor Active Dilated Cm.
What interventions are being tested in trial NCT07056062?
The interventions under investigation include: Calcium carbonate (DRUG).
Who is sponsoring clinical trial NCT07056062?
This trial is sponsored by Arrowhead Regional Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07056062 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Labor Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0
RECRUITING · Phase 2
-
The Role of Oxytocin in the Second Stage of Labor
RECRUITING · NA
-
Early Diagnosis and Intervention for Fetal Malposition in Active Labor and Its Impact on Mode of Delivery
RECRUITING · NA
-
The Effect of Fluids on Aortic VTI During C-section
RECRUITING
-
Fetal Pillow Randomized Controlled Trial
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI